Hemoglobin A1cand fasting plasma glucose levels as predictors of retinopathy at 10 years: The French DESIR study

Archives of Ophthalmology

Volumn 129, Issue 2, 2011, Pages 188-195

  Massin, Pascale ^a   Lange, Céline ^b,c   Tichet, Jean ^d   Vol, Sylviane ^d   Erginay, Ali ^a   Cailleau, Martine ^d   Eschwège, Eveline ^b,c   Balkau, Beverley ^b,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d Institut Inter Regional Pour la Sante   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETINOPATHY; AGED; BLOOD; BLOOD PRESSURE; DIABETIC RETINOPATHY; DIET RESTRICTION; FOLLOW UP; IMPAIRED GLUCOSE TOLERANCE; LABORATORY DIAGNOSIS; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETIC RETINOPATHY; FALSE POSITIVE REACTIONS; FASTING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK FACTORS;

EID: 79951702452     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.353     Document Type: Article

References (27)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183-1197.
2. 1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334.
3. Ulm K. A statistical method for assessing a threshold in epidemiological studies. Stat Med. 1991;10(3):341-349.
4. Wong TY, Liew G, Tapp RJ, et al. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet. 2008;371(9614):736-743. (Pubitemid 351288874)
5. Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia. 2009;52(7):1279-1289.
6. McCartney P, Keen H, Jarrett RJ. The Bedford Survey: observations on retina and lens of subjects with impaired glucose tolerance and in controls with normal glucose tolerance. Diabete Metab. 1983;9(4):303-305. (Pubitemid 14107983)
7. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994; 112(1):92-98. (Pubitemid 24024507)
8. Stolk RP, Vingerling JR, de Jong PT, et al. Retinopathy, glucose, and insulin in an elderly population: the Rotterdam Study. Diabetes. 1995;44(1):11-15.
9. Rajala U, Laakso M, Qiao Q, Keinänen-Kiukaanniemi S. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care. 1998;21(10):1664-1669. (Pubitemid 28449804)
10. Yu T, Mitchell P, Berry G, Li W, Wang JJ. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol. 1998;116(1): 83-89. (Pubitemid 28098899)
11. Gabir MM, Hanson RL, Dabelea D, et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care. 2000;23(8):1113-1118.
12. van Leiden HA, Dekker JM, Moll AC, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care. 2002;25(8):1320-1325. (Pubitemid 41071139)
13. Tapp RJ, Shaw JE, Harper CA, et al; AusDiab Study Group. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003;26(6):1731-1737. (Pubitemid 36929112)
14. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24(2):137-144.
15. Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC. Proliferative retinopathy in NIDDM: incidence and risk factors in Pima Indians. Diabetes. 1989;38(4):435-440. (Pubitemid 19105400)
16. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care. 2003;26(2):320-326. (Pubitemid 36929049)
17. Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye (Lond). 2007;21(4):465-471. (Pubitemid 46564136)
18. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE; Australian Diabetes Obesity and Lifestyle Study Group. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) Study. Diabetes Care. 2008;31(7):1349-1354.
19. McCance DR, Hanson RL, Charles MA, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 1994;308(6940):1323-1328.
20. Balkau B, Eschwege E, Tichet J, Marre M. Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (DESIR). Diabetes Metab. 1997;23(5):428-434. (Pubitemid 27502135)
21. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjølie AK. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia. 1995;38(4):437-444.
22. WHO/IDF Consultation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: 2006. http://www.who.int/diabetes/publications/ Definition %20and%20diagnosis%20of%20diabetes-new.pdf. Accessed November 26, 2010.
23. van Hecke MV, Dekker JM, Nijpels G, et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia. 2005; 48(7):1300-1306. (Pubitemid 41186094)
24. van Leiden HA, Dekker JM, Moll AC, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn Study. Arch Ophthalmol. 2003; 121(2):245-251. (Pubitemid 36184039)
25. Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H. Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract. 2000;49(2-3):181-186. (Pubitemid 30665464)
26. Wong TY, Klein R, Amirul Islam FM, et al. Three-year incidence and cumulative prevalence of retinopathy: the Atherosclerosis Risk in Communities Study. Am J Ophthalmol. 2007;143(6):970-976. (Pubitemid 46764650)
27. Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care. 2007;30(9):2399-2400.